decreased by 30% and 50%, respectively (p < .05 for both), during isoproterenol infusion. pHi decreased in normal animals (p < .01), but tended to improve in diseased animals (NS) during isoproterenol infusion. Freeze-clamp measurements of phosphate metabolites correlated well with the nuclear magnetic resonance data. Intracellular calcium increased from 0.0102 + 0.002 to 0.144 + 0.030 gmol/ml heart water in normal hamsters during isoproterenol infusion. Cardiomyopathic hamsters had a markedly elevated baseline calcium content of 60.82 + 5.85 .mol/ml heart water due to the presence of dystrophic calcification. Isoproterenol did not significantly alter this calcium content. We conclude that in cardiomyopathic hamsters, isoproterenol markedly increases contractile function and energy demand without an associated deterioration in the high-energy phosphate profile. In contrast, normal hamsters are unable to synthesize sufficient ATP to replenish the amount used in meeting the increased workload during isoproterenol infusion. Circulation 77, No. 3, 712-719, 1988 .
THE ROLE of catecholamines in cardiac disease is complex and poorly understood. Adrenergic dysfunction1-5 has been implicated in the pathogenesis of the hereditary polymyopathy seen in a strain of Syrian hamsters designated UM-X7.1, a derivative of the Bio 14.6 strain.6 These animals develop a cardiomyopathy LABORATORY INVESTIGATION-CARDIOMYOPATHY cium overload that is a prominent feature of this myopathy.9-12 The pathologic changes observed in hearts from this myopathic strain are also reminiscent of the cardiac necrosis seen in isoproterenol overdose. 5 Unexpectedly, Jasmin and Proschek13 found that long-term isoproterenol (0.05 mg/kg injection twice daily) prevented development of the myocardial necrotizing process in young cardiomyopathic hamsters. Isoproterenol-treated diseased hamsters also had a 60% reduction in serum creatine kinase and a 75% reduction in myocardial calcium when compared with untreated myopathic hamsters. This study suggests that isoproterenol, when given in appropriate doses, may have beneficial effects in this cardiomyopathic preparation.
Isolated Langendorff heart preparations from cardiomyopathic hamsters in the postnecrotic stage were therefore studied to: (1) determine the hemodynamic effect of adding isoproterenol to the perfusate, (2) correlate myocardial performance with energy metabolism as measured by 31P nuclear magnetic resonance (NMR) spectroscopy, and (3) In a parallel series of experiments, normal and myopathic hearts were frozen during control and isoproterenol perfusion with a stimulator-triggered freeze clamp. This instrument decreases the temperature of the heart from 370 to -800 C in 5 msec. 23 Heart tissue extracts were prepared as described previously. 6 By use of the neutralized extract, samples were analyzed by high-pressure liquid chromatography. For separation of nucleotides, a Beckman chromatograph with a C-18 reverse-phase column was used. For the mobile phase, 19% acetonitrile in 0.03M KH2PO4 with 0.O1M tetrabutylammonium (TBA) phosphate, pH 2.65, was used. Elution was 1 ml/min with detection by a Beckman ultraviolet spectrophotometer at 254 nm. PCr and creatine were analyzed on the same column, but elution was 1.5 ml/min with 0.3% KH2P04 and 0.1% TBA (pH 3.0). Detection was at 210 nm. PCr and creatine and nucleotides were quantified by integration of defined peaks of unknown in relation to integration of defined peaks of known standard concentrations. All were analyzed within the linear range. The concentrations of adenosine, inosine, and hypoxanthine in the coronary effluent were measured by injecting 40 Il on the Beckman C-18 reverse-phase column with use of a 10 min gradient of 0 to 20% methanol in water followed by a 10 min elution time at 20% methanol.
Total intracellular calcium determination. In a parallel series of experiments, total intracellular calcium concentration was determined by measurement of total myocardial calcium content and subtraction of the extracellular fraction determined with KCoEDTA as an extracellular marker.24 26KCoEDTAwas synthesized by the method of Dwyer et al. 27 and added to the Krebs-Henseleit perfusate at a concentration of 0.6 mM. At the end of the control or isoproterenol perfusion period, the hearts were removed from the perfusion apparatus, weighed, and minced. A dry weight was obtained after 72 hr at 1100 C. The difference between wet and dry heart weight yields the volume of heart water assuming 1 g = 1 ml H20. 
Results
Effect of isoproterenol on normal hamster hearts. Table   1 summarizes the hemodynamic changes associated with isoproterenol infusion in normal and myopathic hearts. Normal hamsters had an 83% increase in left ventricular developed pressure after addition of isoproterenol to the perfusate (p < .001 compared with control). Oxygen consumption showed a 25% increase that did not reach statistical significance. Coronary flow, end-diastolic pressure, and heart rate were unchanged.
Representative 31P NMR spectra are shown in figure 2. The improved mechanical performance during isoproterenol infusion was accompanied by a deterioration of the metabolic variables measured by 31P NMR spec- was no significant difference in these variables before and during isoproterenol administration. Baseline total intracellular calcium content in normal hamster hearts as measured by atomic absorption spectroscopy was 0.0102 ± 0.002 kimol/ml of heart water (n = 5). This value increased significantly to 0.144 ± 0.030 pimol/ml of heart water (n = 6) during perfusion with isoproterenol.
Elfect of isoproterenol on cardiomyopathic hamster hearts (figure 2). When perfused with control buffer, cardiomyopathic hamsters had significantly lower mean developed pressure and 02 consumption in comparison with normal hamsters (p < .005 and p < .05, respectively) (see table 1 ). This agrees with data from 180-to 200-day-old cardiomyopathic hamsters studied Table 2 shows that there were no significant differences in the concentrations of adenine nucleotide degradation products (inosine and hypoxanthine) or lactate in the coronary effluent.
Total intracellular calcium concentration during control perfusion was markedly elevated at 60.82 + 5.85 Rmol/ml of heart water (n = 4). During isoproterenol treatment there was a mean decrease to 56.02 + 6.35 [imol/ml of heart water (n = 7), which was not statistically significant.
Correlation of 31P NMR and freeze-clamp measurements. It is important to note that normal perfused hamster hearts have higher Pi values when compared with normal rat hearts perfused with the same Krebs-Henseleit buffer. This is in agreement with previously published reports.14' 29 The baseline PCr/Pi ratio in normal hamsters is therefore lower than the value measured in normal rat hearts.?6 29 Discussion 3'P NMR spectroscopy is uniquely suited for the study of cardiac energy metabolism because of its ability to provide nondestructive, repetitive, and quantitative measurements of bioenergetics in the functioning, intact heart.17-19 The hemodynamic response to therapeutic interventions can therefore be correlated with changes in the high-energy phosphate profile. In this study, 31P NMR spectroscopy was used to evaluate the effects of isoproterenol in a preparation of cardiomyopathy. Traditional biochemical assays were used to confirm the 31P NMR spectroscopy data. In addition, intracellular calcium was measured to pro-CIRCULATION nificant changes in systolic or diastolic pressures at different heart rates. It therefore appears that at 140 mm Hg perfusion pressure, thebesian flow is sufficient to significantly elevate diastolic pressure in failing myopathic hearts. In the present study, all hearts were paced at the same rate (just above the intrinsic rate observed during isoproterenol administration) to control for isoproterenol's chronotropic effect. It is important to note that in cardiomyopathic hamsters, isoproterenol administration not only improved systolic function but also resulted in reduction of the elevated diastolic pressure, suggesting improved diastolic relaxation.
Although high-dose isoproterenol has been reported to have toxic affects in cardiomyopathic hamsters,8 the lower dose used in our study did not result in deterioration of the metabolic variables we evaluated. Although mitochondrial dysfunction is a hallmark of this polymyopathy,35 isoproterenol infusion was associated with a stable and in several cases increased PCr/Pi ratio in the presence of a markedly increased energy demand. PCr/Pi is an energetic index that has been shown to correlate with the phosphorylation 20' 21 which is believed to play a role in regulating mitochondrial respiration and cardiac contractility.36 ATP levels also remained unchanged during isoproterenol infusion. This suggests that in cardiomyopathic hamsters, oxidative phosphorylation was sufficient to meet the increased energy demands imposed by isoproterenol. However, mitochondrial activity remained inefficient in the myopathic hearts since oxygen consumption was 1.8 times higher than in normal hearts at a similar level of increased cardiac performance. To exclude the possibility of ischemia or a significant energy contribution from glycolysis during isoproterenol administration, determinations of lactate and adenine nucleotide degradation products in coronary effluent were made.
Since there was no increase in coronary efflux of either lactate or xanthine and hypoxanthine during isoproterenol treatment, it is unlikely that ischemia or a significant energy contribution via the glycolytic pathway occurred.
Our study also suggests that normal hamster hearts are more sensitive to isoproterenol's deleterious effects since they showed a deterioration in the metabolic profile at the dose that had no adverse effect on the energy profile in diseased hamsters. 24 These characteristics make it a useful marker for myocardial extracellular space.25' 26 The control value for total intracellular calcium reported in this study for normal hamsters correlates well with previously published reports.26' 41 The shortterm infusion of isoproterenol increases total intracellular calcium 14-fold in normal hamsters. This agrees with a recent perfused rabbit heart study42 that documented a 10-fold increase in intracellular calcium after treatment with norepinephrine, a catecholamine similar to isoproterenol. Total intracellular calcium content measured in the cardiomyopathic hamsters was markedly elevated, primarily due to the dystrophic calcification present in these animals.6 7 These calcified deposits are included in the total intracellular calcium measurement obtained by the technique used in this study. In spite of this limitation, it is noteworthy that isoproterenol did not increase the elevated calcium level in these diseased hamsters.
Our findings are consistent with Jasmin and Proschek's report '3 44 4 documented normalization of mitochondrial structure and an increased ATP/creatine ratio in endomyocardial biopsy samples obtained from these patients after dobutamine infusion. This suggests that the hemodynamic benefit results from improved mitochondrial function and energetics. The beneficial action of isoproterenol on cardiomyopathic hamsters therefore appears to have a corollary in dobutamine-treated patients with dilated cardiomyopathy. Despite obvious differences between this animal preparation and human disease, elucidation of the mechanisms involved in isoproterenol's beneficial effect may provide insight into the role of catecholamines in the pathogenesis and treatment of idiopathic dilated cardiomyopathy.
